Literature DB >> 11731619

The protein tyrosine phosphatase-PEST is implicated in the negative regulation of epidermal growth factor on PRL signaling in mammary epithelial cells.

K Horsch1, M D Schaller, N E Hynes.   

Abstract

Treatment of HC11 mammary epithelial cells with the lactogenic hormone PRL promotes differentiation and induction of milk protein gene expression via stimulation of the Janus kinase (JAK)/signal transducer and activator of transcription pathway. We have previously shown that autocrine activation of epidermal growth factor (EGF) receptor interferes with normal PRL-induced differentiation. Here we show that PRL activation of JAK2 was dramatically reduced in HC11 cells pretreated with EGF, demonstrating that the target of EGF receptor activation is JAK2 kinase. Using an in-gel protein tyrosine phosphatase (PTP) assay, we observed that the activity of a 125-kDa PTP was up-regulated in HC11 cells in response to EGF. A specific antiserum was used to demonstrate that the 125-kDa PTP was PTP-PEST and to show that EGF treatment of HC11 cells led to an increase in the level of PTP-PEST. In intact HC11 cells, PTP-PEST was constitutively associated with JAK2, and in response to EGF treatment there was an increased level of PTP-PEST in JAK2 complexes. An in vitro phosphatase assay, using PRL-activated JAK2 as the substrate and lysates from HC11 cells as the source of PTP-PEST, revealed that JAK2 could serve as a PTP-PEST substrate. However, in intact cells the regulation of JAK2 by PTP-PEST was complex, since transient overexpression of PTP-PEST had a negligible effect on PRL-induced JAK2 activation. EGF's negative influence on JAK2 activity was blocked by actinomycin D treatment of HC11 cells, suggesting that EGF induced a protein that mediated the effects of PTP-PEST on JAK2. In support of this model, PTP-PEST-containing lysates from EGF-treated HC11 cells dephosphorylated JAK2 to a greater extent than lysates prepared from control cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11731619     DOI: 10.1210/mend.15.12.0743

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  5 in total

1.  Prolactin potentiates transforming growth factor alpha induction of mammary neoplasia in transgenic mice.

Authors:  Lisa M Arendt; Teresa A Rose-Hellekant; Eric P Sandgren; Linda A Schuler
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

2.  PAK1-Nck regulates cyclin D1 promoter activity in response to prolactin.

Authors:  Jing Tao; Peter Oladimeji; Leah Rider; Maria Diakonova
Journal:  Mol Endocrinol       Date:  2011-06-30

3.  Dominant negative Ras enhances lactogenic hormone-induced differentiation by blocking activation of the Raf-Mek-Erk signal transduction pathway.

Authors:  Maria Grazia Cerrito; Traci Galbaugh; Weihan Wang; Treasa Chopp; David Salomon; Mary Lou Cutler
Journal:  J Cell Physiol       Date:  2004-11       Impact factor: 6.384

4.  The role of protein tyrosine phosphatases in the regulation of allergic asthma: implication of TC-PTP and PTP-1B in the modulation of disease development.

Authors:  Philippe Pouliot; Sébastien Bergeron; André Marette; Martin Olivier
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

5.  Complex prolactin crosstalk in breast cancer: new therapeutic implications.

Authors:  Kristopher C Carver; Lisa M Arendt; Linda A Schuler
Journal:  Mol Cell Endocrinol       Date:  2009-04-01       Impact factor: 4.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.